Top of the Street: Shell, Repsol, Ambu, SSE, DSM-Firmenich

Ambu A/S

09/01/2025 12:02

A round-up of notable broker activity this morning from Europe's
top-ranked* analysts:
    
    ** Carnegie raises Danish medical devices maker Ambu
 AMBUb.CO  to "buy" from "hold" following the company's share
price drop and growth potential aided by stronger US dollar
    ** UBS upgrades Spain's Repsol  REP.MC  to "buy" from
"neutral" saying it sees a rebound for the oil and gas company's
shares on improved economic outlook in 2025
    ** UBS raises Shell  SHEL.L  to "buy" from "neutral" citing
an opportunity for $6 billion of additional cost savings and
sees the company as being on track to meet or even surpass its
2025 targets
    ** UBS raises British power generator and network operator
SSE  SSE.L  to "buy" from "neutral" on valuation
    ** Stifel upgrades Amsterdam-listed chemicals maker
DSM-Firmenich  DSFIR.AS  to "buy" from "hold" seeing potential
additional shareholder returns
    
    
(*Analyst rankings from Thomson Reuters StarMine. The scale is
from 1-star to 5-star with 5 being the best. Analysts are ranked
on earnings accuracy as well as relative performance of
recommendations over trailing 12-month & 24-month periods.)


 (Reporting by Elviira Luoma and Tiago Brandao)
 ((Elviira.luoma@thomsonreuters.com))